AIM: To prospectively examine the association between presence of Streptococcus bovis (S. bovis) in colonic suction fluid and the endoscopic findings on colonoscopy. METHODS: From May 2012 to March 2013, 203 consecutive patients who underwent colonoscopy for any reason were enrolled in the study. Exclusion criteria included: antibiotic use in the previous month, age younger than 18 years, and inadequate preparation for colonoscopy. The colonoscopy was performed for the total length of the colon or to the occluding tumor. The endoscopic findings were registered. Samples were obtained proximal to the colonoscopic part of the suction tube from each patient and sent to the clinical microbiology laboratory for isolation and identification of S. bovis. Samples were incubated in enrichment media with addition of antibiotic disks for inhibition of growth of Gram-negative rods. The samples were seeded on differential growth media; suspected positive colonies were isolated and identified with Gram staining, catalase, and pyrrolidonyl arylamidase tests, and further identified using a VITEK2 system. Statistical analyses were performed using the Student's t and χ(2) tests. RESULTS: Of the 203 patients recruited, 49 (24%) patients were found to be S. bovis carriers; of them, the endoscopic findings included: 17 (34.7%) cases with malignant tumors, 11 (22.4%) with large polyps, 5 (10.2%) with medium-sized polyps, 6 (12.2%) with small polyps, 4 (8.1%) with colitis, and 6 (12.2%) normal colonoscopies. Of 154 patients found negative for S. bovis, the endoscopic findings included: none with malignant tumors, 9 (5.8%) cases with large polyps, 11 (7.1%) with medium-sized polyps, 26 (16.9%) with small polyps, 7 (4.5%) with colitis, and 101 (65.6%) normal colonoscopies. S. bovis (Gram-positive coccus) is considered part of the normal intestinal flora. There is an association between S. bovis bacteremia and colonic neoplasia. It is not well understood whether the bacterium has a pathogenetic role in the development of neoplasia or constitutes an epiphenomenon of colorectal neoplasms. There was a clear relationship between positivity for S. bovis in colonic suction fluid and findings of malignant tumors and large polyps in the colon. CONCLUSION: There is an association between S. bovis bacteremia and malignant colonic lesions; this should prompt for development of a reliable screening method for advanced colonic lesions.
AIM: To prospectively examine the association between presence of Streptococcus bovis (S. bovis) in colonic suction fluid and the endoscopic findings on colonoscopy. METHODS: From May 2012 to March 2013, 203 consecutive patients who underwent colonoscopy for any reason were enrolled in the study. Exclusion criteria included: antibiotic use in the previous month, age younger than 18 years, and inadequate preparation for colonoscopy. The colonoscopy was performed for the total length of the colon or to the occluding tumor. The endoscopic findings were registered. Samples were obtained proximal to the colonoscopic part of the suction tube from each patient and sent to the clinical microbiology laboratory for isolation and identification of S. bovis. Samples were incubated in enrichment media with addition of antibiotic disks for inhibition of growth of Gram-negative rods. The samples were seeded on differential growth media; suspected positive colonies were isolated and identified with Gram staining, catalase, and pyrrolidonyl arylamidase tests, and further identified using a VITEK2 system. Statistical analyses were performed using the Student's t and χ(2) tests. RESULTS: Of the 203 patients recruited, 49 (24%) patients were found to be S. bovis carriers; of them, the endoscopic findings included: 17 (34.7%) cases with malignant tumors, 11 (22.4%) with large polyps, 5 (10.2%) with medium-sized polyps, 6 (12.2%) with small polyps, 4 (8.1%) with colitis, and 6 (12.2%) normal colonoscopies. Of 154 patients found negative for S. bovis, the endoscopic findings included: none with malignant tumors, 9 (5.8%) cases with large polyps, 11 (7.1%) with medium-sized polyps, 26 (16.9%) with small polyps, 7 (4.5%) with colitis, and 101 (65.6%) normal colonoscopies. S. bovis (Gram-positive coccus) is considered part of the normal intestinal flora. There is an association between S. bovis bacteremia and colonic neoplasia. It is not well understood whether the bacterium has a pathogenetic role in the development of neoplasia or constitutes an epiphenomenon of colorectal neoplasms. There was a clear relationship between positivity for S. bovis in colonic suction fluid and findings of malignant tumors and large polyps in the colon. CONCLUSION: There is an association between S. bovis bacteremia and malignant colonic lesions; this should prompt for development of a reliable screening method for advanced colonic lesions.
Authors: Beatriz Romero; María-Isabel Morosini; Elena Loza; Mercedes Rodríguez-Baños; Enrique Navas; Rafael Cantón; Rosa Del Campo Journal: J Clin Microbiol Date: 2011-07-13 Impact factor: 5.948
Authors: P Josefson; K Strålin; A Ohlin; T Ennefors; B Dragsten; L Andersson; H Fredlund; P Mölling; P Olcén Journal: Eur J Clin Microbiol Infect Dis Date: 2011-03-04 Impact factor: 3.267
Authors: Julian R Marchesi; Bas E Dutilh; Neil Hall; Wilbert H M Peters; Rian Roelofs; Annemarie Boleij; Harold Tjalsma Journal: PLoS One Date: 2011-05-24 Impact factor: 3.240
Authors: Han Shuwen; Da Miao; Qi Quan; Wu Wei; Zhang Zhongshan; Zhang Chun; Yang Xi Journal: J Cancer Res Clin Oncol Date: 2019-08-10 Impact factor: 4.553
Authors: Julia Butt; William J Blot; Lauren R Teras; Kala Visvanathan; Loïc Le Marchand; Christopher A Haiman; Yu Chen; Ying Bao; Howard D Sesso; Sylvia Wassertheil-Smoller; Gloria Y Ho; Lesley F Tinker; Richard M Peek; John D Potter; Timothy L Cover; Laura H Hendrix; Li-Ching Huang; Tim Waterboer; Michael Pawlita; Meira Epplein Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-07-23 Impact factor: 4.254
Authors: Ritesh Kumar; Jennifer L Herold; Deborah Schady; Jennifer Davis; Scott Kopetz; Margarita Martinez-Moczygemba; Barbara E Murray; Fang Han; Yu Li; Evelyn Callaway; Robert S Chapkin; Wan-Mohaiza Dashwood; Roderick H Dashwood; Tia Berry; Chris Mackenzie; Yi Xu Journal: PLoS Pathog Date: 2017-07-13 Impact factor: 6.823
Authors: Lígia A B M Mendonça; Rosângela Dos Santos Ferreira; Rita de Cássia Avellaneda Guimarães; Alinne P de Castro; Octávio L Franco; Rosemary Matias; Cristiano M E Carvalho Journal: Front Oncol Date: 2018-09-05 Impact factor: 6.244
Authors: John Culver Taylor; Xinsheng Gao; Juan Xu; Michael Holder; Joseph Petrosino; Ritesh Kumar; Wen Liu; Magnus Höök; Chris Mackenzie; Andrew Hillhouse; Wesley Brashear; Maria Patricia Nunez; Yi Xu Journal: PLoS Pathog Date: 2021-01-06 Impact factor: 6.823
Authors: Bruno Périchon; Julian Lichtl-Häfele; Emma Bergsten; Vincent Delage; Patrick Trieu-Cuot; Philippe Sansonetti; Iradj Sobhani; Shaynoor Dramsi Journal: Front Cell Infect Microbiol Date: 2022-03-11 Impact factor: 5.293